肥胖与子宫内膜癌患者生存期的关联
该研究回顾了1999年至2016年1732例子宫内膜癌患者的资料,采用Kaplan-Meier生存曲线和Cox回归分析肥胖与生存的关系。结果显示肥胖与较年轻诊断年龄和较低分期相关,且在3-4期非子宫内膜样癌中肥胖与疾病特异性生存改善相关。
要点
- 肥胖与子宫内膜癌诊断时较年轻及较低分期线性相关。
- 年轻、子宫内膜样组织学、较低分期和他汀使用与死亡风险降低独立相关。
- 3-4期非子宫内膜样癌中,年龄>65岁的肥胖患者显示生存获益。
核心结论
- 肥胖与子宫内膜癌诊断时较年轻和较低分期疾病相关。
- 肥胖与3期和4期非子宫内膜样子宫内膜癌的疾病特异性生存改善相关。
研究设计与样本
- 经IRB批准后,回顾1999年至2016年诊断并治疗的子宫内膜癌女性记录,摘取组织病理学、治疗和人口学数据。
- 通过查询社会保障死亡指数确认死亡,使用Stata 14.0进行Kaplan-Meier生存曲线和Cox回归建模。
- 共1732例可评估患者。
主要发现
- 正常体重、超重、肥胖和病态肥胖患者在诊断年龄、组织学(子宫内膜样 vs 非子宫内膜样)、分期、种族、分级、高血压、高脂血症、糖尿病和治疗方面存在显著差异(p < 0.01)。
- 诊断年龄较年轻与肥胖程度增加呈线性关联(p < 0.01),R² = 0.04。
- 年轻、子宫内膜样组织学、较低分期和他汀使用与死亡风险降低独立相关(p < 0.01)。
- 在非子宫内膜样组织学的分层分析中,3期和4期疾病且年龄超过65岁的患者中,肥胖女性显示生存获益(p = 0.02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity confers an overall increased risk for development of endometrial cancer. However there are conflicting reports regarding the effect of obesity on patients' overall and disease specific survival. The purpose of this study was to evaluate the effect of obesity on survival in women with endometrial cancer. METHODS: After IRB approval, records of women with diagnosis and treatment of endometrial cancer from 1999 to 2016 were abstracted for histopathological, treatment and demographic data. Death was confirmed by query of the Social Security Death Index. Kaplan Meier survival curves and Cox regression modeling was performed with Stata version 14.0. RESULTS: Of 1732 evaluable patients, there were significant differences in age at diagnosis, histology (endometrioid versus non-endometrioid), stage, race, grade, hypertension, hyperlipidemia, diabetes, and treatment between normal weight, overweight, obese, and morbidly obese patients (p < 0.01). There was a linear association of younger age at diagnosis with increasing obesity (p < 0.01) R2 = 0.04. Younger age, endometrioid histology, lower stage, and statin use were independently associated with decreased hazard of death (p < 0.01). However, in stratified analysis of non-endometrioid histologies, patients with Stage 3 and 4 disease over the age of 65 showed a survival benefit for women associated with obesity (p = 0.02). CONCLUSIONS: Obesity is associated with younger age at diagnosis and earlier stage disease. Obesity is associated with improved disease specific survival for stage 3 and 4 non-endometrioid endometrial cancers.
引用
- Van Arsdale A, Miller DT, Kuo DY, et al. Association of obesity with survival in patients with endometrial cancer. Gynecol Oncol. 2019. PMID: 31060820. doi:10.1016/j.ygyno.2019.03.258
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。